Reddit Posts
2 “Strong Buy” Penny Stocks With Over 400% Upside on the Horizon
Rockets that are loaded: STAB, CYRN, SATL, DRTS, SKYH, CYN, BWV, MLTX, PTPI, ALLG
$THCA - Low Float SPAC near NAV, with squeeze potential
Real Potential $ISPO 2.0 -- $DRTS Moon shot incoming!
DRTS is an early candidate to a squeeze!! Buy now get paid in a week.
$DRTS Annual Report “In Coming Days” Will include share breakdown
Mentions
DRTS and IBRX doing particularly well and looks like SLS is on an upswing.
Ok ride IBXR up then put gains into DRTS ride that up put gains into NLST ride that up put gains into SLS ride that up put gains into ASTS get a pina colada.
$DRTS see first overseas approval in Japan for it's DaRT therapy to treat unresectable locally advanced or recurrent head and neck cancer. FDA and EMA approvals next
DRTS just posted about it [https://www.reddit.com/r/smallstreetbets/comments/1rcqx89/a\_chart\_always\_shows\_what\_the\_insiders\_know\_let/?utm\_source=share&utm\_medium=web3x&utm\_name=web3xcss&utm\_term=1&utm\_content=share\_button](https://www.reddit.com/r/smallstreetbets/comments/1rcqx89/a_chart_always_shows_what_the_insiders_know_let/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button)
**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** FDA Breakthrough Device Designation FDA TAP program inclusion FDA MDSAP certification FDA IDE’s for five cancers and counting FDA PHASE 3 completion in H1 2026 FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) FDA approval for commercial factory in the US, with other factories built and more in planing 100% tumor response rate in early FDA trials Effective against all tumor types, including the most high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… Activates immune system 55+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, Italy, Japan…) Patents, IP and more…
**Upcoming catalysts for DRTS:** **PMDA approval in Japan** Expected to be announced any day **Keytruda trial for combination therapy** Updates from combination trials with Merck’s Keytruda, exploring systemic and metastatic potential **GBM FDA trial** Two months ago it was announced Alpha Tau has successfully treated the first GBM patient, historic news, with more patients and updates coming every month - including this months update about the second patient being successfully treated and both patients doing great **FDA Pancreas trial** Earlier than that it was announced that Alpha Tau has successfully treated a Pancreatic Cancer patient as well, after successfully completing a Pancreatic Cancer study with tens of patients in Canada. Progress and updates from the Pancreas trial could be shared along the way **Phase 3 recruitment completion for cSCC** Q1 2026, the early results are amazing **cSCC FDA approval submission** Already started submitting the data **New FDA trials launching** Most recently prostate, while next could be head & neck **Commercial manufacturing facility completion** Already approved by the FDA **Presenting at more conferences** Including Citi’s 2026 Oncology Leadership Summit this month and others **Other stock related events** Potential strategic partnerships or licensing deals, enabled by regulatory and manufacturing readiness. Investor re ratings, transitioning from pre revenue clinical stage to commercial oncology company is a major re-rating moment. Future label expansions leveraging existing approvals and platform scalability.
Start with the basics. The market cap for DRTS is currently at $600M. This, combined with horrible PR, has ensured that the volume in the stock and the market cap until recently, has kept institutional investors away. This was, until January, a pure retail play. Any one of the solid tumor targets that Alpha Tau is targeting is a multi-Billion dollar market. Who’s the current leader in GBM cancer? There isn’t one. Who’s the leader in PanC? Sadly, it’s a cocktail of horrible chemo poisons or, if you’re lucky, they’ll surgically do a replumbing of your innards. Alpha Tau has already shown incredible results in PanC and every month there is another FDA approved win in GBM. Gotta love clockwork catalysts if you’re a biotech investor. The company sits in the radiapharm space where M&A has been steroid level active. Previous deals with inferior treatments have gone in the $4B range (hearken back to their current market cap and simple math makes your wallet itch.) Keytruda is Merck’s $30B baby. It’s the biggest money making drug on planet earth. It has a whopping 30% success rate. Recent studies of Alpha Tau in conjunction with Keytruda push that efficacy rate north of 90%. What’s that worth to a thirty billion United States dollars drug? All of that is why I’m long. Here’s why I’m planning my retirement off of $DRTS. Something miraculous is happening because of the way their brachytherapy works. The local application of the alpha radiation isn’t just destroying the double helix of the tumors dna strand; somehow the immunity system is being retrained systemically from the local application of the radiation. If you’ve ever dreamed of being insanely wealthy, reread that last sentence a few times. I don’t believe they set out to radically upgrade the compromised immunity system via the local application of radiation but those are the results they’ve shown and reported at the JP Morgan conference a few weeks ago. As of today, all of DRTS tests are against people who are wiped out. No hope. Inoperable. Failed chemo. Shattered and burned by radiation. And they’re having amazing results. What do you think could happen if what is essentially an outpatient process (saving misery for the patient and money for the insurers) that anyone who’s ever done a biopsy (Alpha Tau made it nearly identical to a biopsy to ensure easy training) could perform hit not at the last line of attack but the first? What if patients were seeing the same efficacy results before their bodies (and souls) were depleted? Would any oncologist in the world pump their patient full of chemo and send them home with a poison filled fanny pack if they could just destroy the solid tumor in the office? You know the answer. It’s a great day to be a $DRTS investor and it’s looking like very dark days indeed if you’re a solid cancer tumor. Obviously, this is not financial advice and you should do your own research. But yes, I’m long on DRTS because: 1. Fuck cancer and 2. I like making millions while saving millions of lives.
IBRX blows up I roll into DRTS>DRTS blows up I roll into SLS> SLS blows up I roll into ASTS= I'll have $1,000 😎
bought the PATH dip and rolled DRTS calls
Today DRTS is holding a sideways trend. Two catalysts are expected to emerge in the first quarter of 2026 and will suddenly be confirmed. Given that investor anticipation for the expected event is high, the impact on the stock will be equally strong once positive responses arrive! Patience is the winning weapon.
DRTS will have positivity on all PMDA catalysts and will also prepare a platform for trading of alpha radio technology produced in hempair for trading all over the world will suddenly explode
Ah cool! I'm heavy in SLS and DRTS. Just dive right in small bios while I'm new to investing 😁
Waiting for DRTS, NLST, SLS to do anything first so I can ride the wave 👋
Recommendation to look into DRTS. A revolutionary cancer treatment that is at the turning point from clinical-stage pre-revenue company to commercial platform. The patented tech delivers alpha radiation into the tumors, killing the cancer cells while sparing healthy tissue (and even awakens the immune system and teaches it to fight cancer elsewhere in the body). It’s effective against all solid tumors, even the most high unmet needs like Pancreas and GBM (both have active in-human FDA trials with amazing results). DRTS has 55+ clinical sites worldwide, FDA Breakthrough Device Designation, fully funded with an experienced management team. NFA and DYOR but worth your time!
Learn all you can. Use a play money account to practice without losing anything for a few months. RKLB is a good company and stocks go up amd down. If you're investing you want it to go up over months or years. If your swing trading you want it to go up for a few days or weeks and sell. Thats jard to do and if you're only doing it with 100$ you're only gonna make $20 sometime. Focus on becoming valuable yourself so you can make more money and have more to save and invest. Many people will tell you too Voo and chill and that will be profitable in the future. If you want higher returns split up your investment money and pick 4 or 5 stocks and etfs that are in different fields and buy them. But stop losses on them. I do 15% below the price I paid. I like stocks that are already doing well and when they go up a good amount I change the stop loss to 15% under the new price. Here are some of my faves right now: IEZ, UWY, FIX, SII, DRTS. Good luck bro! STOP LOSS!
ASTS, RKLB, NBIS, DRTS, PL, RCAT take your pick or maybe the TSMCs will still be the next tsmc you never know
Uuuuuuuu! Also NLST buyout and DRTS approvals.
Schwab tells me i need to place an initial order through a broker for DRTS.
we want all forms of advancement to defeat cancer to succeed that is without question. those of you who are excited about this please check out the company DRTS. their alpha particle delivery device is defeating cancer tumors in all sorts of cancers and is still awaiting fda approval. it is about to receive approval in japan and the company is poised to manufacture their own products to bring to market. also check out IBRX and SLS. fuck cancer
Do you have a bank account and an app for it? You can probably use your app. Look for an Investment option on the menu. You can buy stock by searching for the stock then choosing the amount you want and choose Market Price. Investing is complicated and, like most things in life, people are greedy and foolish and opportunistic. You can buy a stock in one company or an etf which is like a group of companies. Usually the same type of company, like oil companies. These can be less volatile because the companies all even out. Many people will tell you to invest in a safe, broad etf that can get you 10% ish a year returns. That's only $22 dollars at the end of the year. You will probably want to aim for more than that. If you have more than one stock it will be better in case one of them goes down. Look into these stocks. Go to Google financial and see how much they've gained this year and how much they've gained in the last year. Add them to your google financial watchlist. SII is a Mining and Metals etf. They have a great team and great performance. EWY is a South Korea etf. DRTS is a cancer fighting company that will grow fast if they get fda approval. FIX is a heating and cooling company that has been growing for a long time. IEZ is an oil equipment company. Watch what they do for a few days and invest in one or two of them. Then keep reading and learning everything you can. Investing as much as you can every week is important. If it's invested it will grow. If you spend it it's gone. Message me if you like I can help more. Good luck, brother! P.s. You can invest in KORU and your $20 will probably triple in a few months. Then you can take that money and invest in the safer options.
Congrats and best of luck! Would love to see you in the DRTS_Stock community
Yes, she had an abysmal run (for years), but has been on fire the last 18 months. Anyway DRTS getting added to one of her ETFs is a signal that it’s getting noticed. The reason to buy IS NOT Cathie Wood, the reason to buy is DRTS is the best risk/reward opportunity on the market imo, that’s why ARK bought and that’s why you should look into it.
As someone who owns DRTS I appreciate him doing the repeat posts. I would rather someone who truly knows the ins and outs of the company and the updates to do the posting over multiple people who don’t really know what they’re talking about.
I’ve been in on DRTS for about a month and I’m in for the long haul.
Its moving forward.... lets fight the cancer fiercly DRTS 💪🏽💰
Love DRTS. Also loading up on TOI before March 5th earnings.
DRTS success means many lives saved, on top of that all the money made is a bonus
**To learn more about what DRTS has going on read the CEO letter to Shareholders:** [https://www.alphatau.com/single-post/alpha-tau-issues-letter-to-shareholders-five-concurrent-trials-in-the-u-s-with-multiple-significan](https://www.alphatau.com/single-post/alpha-tau-issues-letter-to-shareholders-five-concurrent-trials-in-the-u-s-with-multiple-significan)
**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** FDA Breakthrough Device Designation FDA TAP program inclusion FDA MDSAP certification FDA IDE’s for **five** cancers and counting **FDA PHASE 3** completion in H1 2026 FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) FDA approval for commercial factory in the US, with other factories built and more in planing 100% tumor response rate in early FDA trials Effective against all tumor types, including the most high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… Activates immune system **55+ clinical sites worldwide** (including USA, UK, Canada, France, Germany, Russia, Italy, Japan…) Patents, IP and more…
**Upcoming catalysts for DRTS:** **PMDA approval in Japan** Expected to be announced any day **Keytruda trial for combination therapy** Updates from combination trials with Merck’s Keytruda, exploring systemic and metastatic potential **GBM FDA trial** Two months ago it was announced Alpha Tau has successfully treated the first GBM patient, historic news, with more patients and updates coming every month - including this weeks update about the second patient being successfully treated and both patients doing great! **FDA Pancreas trial** Earlier than that it was announced that Alpha Tau has successfully treated a Pancreatic Cancer patient as well, after successfully completing a Pancreatic Cancer study with tens of patients in Canada. Progress and updates from the Pancreas trial could be shared along the way **Phase 3 recruitment completion for cSCC** Q1 2026, the early results are amazing **cSCC FDA approval submission** Already started submitting the data **New FDA trials launching** Most recently prostate, while next could be head & neck **Commercial manufacturing facility completion** Already approved by the FDA **Presenting at more conferences** Including Citi’s 2026 Oncology Leadership Summit this month and others **Other stock related events** Potential strategic partnerships or licensing deals, enabled by regulatory and manufacturing readiness. Investor re ratings, transitioning from pre revenue clinical stage to commercial oncology company is a major re-rating moment. Future label expansions leveraging existing approvals and platform scalability.
Exactly, she earned the bad name she has, but she’s actually been on fire for the past 18 months, and she’s not the story just a symptom that DRTS is being noticed
Maybe you’ll be the one to find the next DRTS catalyst!
Happy to see DRTS rising nicely today!
The Blue Owl find was very interesting. Institutions joining is a great sign DRTS is primed for the next leap.
DRTS is a great story. I wish them and all other companies seeking a treatment for cancer much success.
Amazing to see someone sharing real information on a real stock. I am already long on $DRTS and that's before they got the two GBM patients treated. This ain't a pharmaceutical tested on rats. This is brachytherapy radiation tested on humans with the WORST forms of cancer (GBM, Pancreatic, etc.) The team at Alpha Tau has proven the localized alpha radiation treatment works and now it's just a matter of time. BEAR CASE: It's biotech. If that's not a bear case boilerplate, I don't know what to tell you.
Why would you say so? I’ve been an honest part of the Reddit community for years Been posting specifically about DRTS since sub 3$ and haven’t sold (even added last week)
DRTS is a Dart Throw. Would rather be in something like $NGEN.
Not everything! I did my best, but there are some gems if you read closely, like the combination therapy trial with Keytruda (the #1 selling drug in the world). Small sample size but it boosted the response rate from 19% for Keytruda alone to 100%(!!!) with the DRTS Alpha DaRT treatment.
**Upcoming catalysts for DRTS:** **PMDA approval in Japan** Expected to be announced any day **Keytruda trial for combination therapy** Updates from combination trials with Merck’s Keytruda, exploring systemic and metastatic potential **GBM FDA trial** Two months ago it was announced Alpha Tau has successfully treated the first GBM patient, historic news, with more patients and updates coming every month - including this update about the second patient being successfully treated and both patients doing great! **FDA Pancreas trial** Earlier than that it was announced that Alpha Tau has successfully treated a Pancreatic Cancer patient as well, after successfully completing a Pancreatic Cancer study with tens of patients in Canada. Progress and updates from the Pancreas trial could be shared along the way **Phase 3 recruitment completion for cSCC** Q1 2026, the early results are amazing **cSCC FDA approval submission** Already started submitting the data **New FDA trials launching** Most recently prostate, while next could be head & neck **Commercial manufacturing facility completion** Already approved by the FDA **Presenting at more conferences** Including Citi’s 2026 Oncology Leadership Summit this month and others **Other stock related events** Potential strategic partnerships or licensing deals, enabled by regulatory and manufacturing readiness. Investor re ratings, transitioning from pre revenue clinical stage to commercial oncology company is a major re-rating moment. Future label expansions leveraging existing approvals and platform scalability.
**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** FDA Breakthrough Device Designation FDA TAP program inclusion FDA MDSAP certification FDA IDE’s for **five** cancers and counting **FDA PHASE 3** completion in H1 2026 FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) FDA approval for commercial factory in the US, with other factories built and more in planing 100% tumor response rate in early FDA trials Effective against all tumor types, including the most high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… Activates immune system **50+ clinical sites worldwide** (including USA, UK, Canada, France, Germany, Russia, Italy, Japan…) Patents, IP and more…
DRTS is such a great developing company. The trials they are running now can really revolutionize cancer treatment. I hope they and all other companies looking for a cure/treatment suceed.
**To learn more about what DRTS has going on read the CEO letter to Shareholders:** [https://www.alphatau.com/single-post/alpha-tau-issues-letter-to-shareholders-five-concurrent-trials-in-the-u-s-with-multiple-significan](https://www.alphatau.com/single-post/alpha-tau-issues-letter-to-shareholders-five-concurrent-trials-in-the-u-s-with-multiple-significan)
She earned her bad name, but she’s been on fire the past 18 months. Also she’s not the story, look into DRTS and you’ll understand why one of her ETFs was eager to add it
**DRTS** [https://www.alphatau.com/single-post/alpha-tau-issues-letter-to-shareholders-five-concurrent-trials-in-the-u-s-with-multiple-significan](https://www.alphatau.com/single-post/alpha-tau-issues-letter-to-shareholders-five-concurrent-trials-in-the-u-s-with-multiple-significan)
Well “like DRTS will” is tricky, since IBRX is already 10X the market cap, so DRTS has much more room to grow. They could both be very successful, I could understand why many like IBRX, but in my eyes it had already gained a lot of value, while DRTS is very de-risked and pre the potential “explode” up
Different companies do it different ways. They are often research based startups with no manufacturing ability that are designed to be picked up. DRTS is a device manufacturer not a drug designer.
Yeah for me SLS is a safer bet, DRTS is looking good though.
Have you seen the DRTS ORR and DCR PanC numbers?
Im interested in the deeper dive on DRTS
Nope. SLS and I had a quick fling but it never got any deeper than that. I don’t see the same level of results as DRTS has produced consistently.
Just bought into DRTS with 1,450 shares 😬 Fingers crossed!
Have you done extensive DD on SLS? I'm curious if you've researched both equally and still have more confidence in DRTS.
Happy to share! Good on you for asking the right questions! If you want to keep up with it please join us in the DRTS_Stock community
Fair question, I’ll answer for DRTS since it’s the position I have out of the three. DRTS is a device/treatment, that’s a whole different category from a risk and approval standpoint. It’s physics based, once you understand how it works you’ll understand the de-risking factor and excitement. The patented tech is injecting Alpha radiation (which is much more fatal to the cancer cells and has very short range) into the tumor, that way killing it while sparing healthy tissue. It’s the same exact treatment for all solid tumors, and has yet to find a tumor that doesn’t respond after dozens tested. Since the delivery is like a regular biopsy (so no special training needed to use it), and the dose of radiation is so low it’s safe to send in the mail and treat in any regular procedure room, the clinical trials are almost like going through the motions until the approval (with 100% tumor response rate in early FDA trials). There are 50+ clinical sites worldwide (US, UK, Canada, Russia, France, Italy, Germany, Japan…), with Japan (PMDA) set to approve very soon and FDA phase 3 data already being submitted as we speak. Hundreds of patients have been successfully treated to date. And what might be most exciting is two things: 1. It could treat even the most high unmet needs cancers, with Pancreatic and GBM already being trialed in the US both with successfully treated patients. 2. The local treatment preserves the immune system, awakens it and trains it to fight cancer elsewhere in the body, proving potential for systemic and metastatic treatments (and already being trialed in combination with Keytruda, boosting the response rate from 19% to 100%).
Sellas's trial's simple math looks overwhelming, too. I definitely wish I could pour a bunch of money into all three before any of them pop. DCAing from here and checking for any news or update haha. Are you overwhelmingly invested in DRTS?
DRTS is the one that will change peoples lives both in response to solid tumors and financially. The others are high risk/high reward gambling. DRTS is simple math. A $600M market cap company that hits even one of their 5+ targets is a $4B company. If they hit all 5, you’ll never work or worry about money again. Let me know if you need a deeper dive. I’ve DD’d DRTS to a degree beyond any other stock I’ve ever bought.
The sad but beautiful thing about the cancer market is that there’s no real competition. All companies are needed and all could succeed. So while rooting for all three, my money is in DRTS. DRTS has a revolutionary cancer treatment, that could be combined with any other treatment, it’s a device and not a drug, has proven to be effective against all solid tumors tested to date (dozens), including the most high unmet needs cancer like Pancreas and GBM. And while the treatment is local (100% response rate in early FDA trials), it has proven to have an immune effect, potentially evolving into a systemic treatment as well. They are fully financed through commercialization (including completing the commercial manufacturing facility in New Hampshire), have an experienced team with past success, are an absolute FDA darling (they have 5! concurrent FDA IDEs, FDA Breakthrough Device Designation, FDA TAP program, MDSAP certification, regular meetings with the FDA and more), already started submitting the Phase 3 data for FDA approval, and are expecting PMDA approval in Japan very soon.
I’m not in IBRX but in SLS and DRTS. Hit my threshold for speculative stocks investments. Waiting on one of these including HUMA and ARSMF to moon, hopefully.
DRTS (was at 4.83 usd within last month so under 5 as per rules)
Safe investment, would be Google. Might see some fluctuations, but long term should be a pretty safe investment. For a more aggressive investment, DRTS. High risk since it is biotech and relies of the FDA and PMDA approvals, but they are making huge progress in a very difficult industry. It’s high risk, high reward.
**DRTS** Here’s why: https://www.alphatau.com/single-post/alpha-tau-issues-letter-to-shareholders-five-concurrent-trials-in-the-u-s-with-multiple-significan
DRTS ftwwww and SLS BIOTECH HEAVY PORTFOLIO MF WHATS DIVERSIFYING 🗣️🗣️🗣️🗣️
Go all in on IBRX. They present amazing updates tomorrow at a conference. Interests mounts on Sunday. Stock rockets at opening Monday. Take profit and put it on SLS. They announce a successful early stop to their trial. Stock rockets. Take profit and go all in on DRTS. Japan approves their device Monday after close. Stock rockets Tuesday morning. $2000>$4000>$8000>$16000. Should be easy.
Appreciate you looking out for the community, but ask around and check my track record. Been helping many here for a long time, and sharing DRTS for the benefit of others. It’s ok to think otherwise, but that’s the truth.
At this stage don’t put any real money in. Give yourself a challenge to try and research the company Alpha Tau Medical (ticker DRTS). Try to understand what they do. What the value is. Is it a good investment? You’ll learn a lot from the process before you make any actual decisions.
Great to hear, welcome! If you got any questions about DRTS or really anything about stocks feel free to reach out I’d love to help!
DRTS is the actual stock. DRTSW are the warrants (from the IPO). They have significant differences, best way to put it is if you know options the warrants are similar to that, but if you don’t really understand what the warrants are should probably not trade them. Me personally, NFA and DYOR, although I’m long and many in the community love the warrants, I would go with the stock.
The DRTS CEO holds 13% (!) of the company and won’t sell a single stock
Happy to share! And again thanks for commenting, would love to hear back from you if you get the chance to check the presentation out (either here or in the DM or in the community DRTS_Stock subreddit)
Have you had a chance to look at the warrants? I’m long DRTS but many in the community love the warrants
If it was a sure thing DRTS would be at 50+, but I’m optimistic it looks promising and is greatly needed!
Can’t argue with Grandma, but might want to update her about what DRTS has going for them (wish I could attach the meme)
Great question, I wrote about the data gap yesterday in the community. Most people don’t know about DRTS, of those who hear about it most don’t understand, and even of those who take the time to learn many don’t believe. That’s why I’m motivated to post about it, I believe there is so much upside just from the potential exposure and eventual pricing in that will occur, and on top of that there is so much growth upside.
Could you tell us a bit more about IPSC here? And why it went up and if you believe it still has more to gain? And have you heard of DRTS?
Maybe the hardest, but DRTS started the trial and already successfully treated the first patient: https://www.alphatau.com/single-post/alpha-tau-successfully-treats-first-patient-in-its-u-s-trial-for-patients-with-recurrent-glioblasto Besides its the same treatment for all solid tumors, with 100% response rate in the dozens of tumor types tested, so it’s just about proving it’s safe to treat and keeps the effectiveness which it seems it is.
I have 3 levels for DRTS: 1. Near term (now) it’s worth 10-15 easy. Watch it reach that soon. 2. Mid term could get as high as 30-40, if the clinical results hold up these amazing results (could even get better) that’s the fair value. 3. If DRTS doesn’t get bought out before the Pancreas and GBM approvals, this is a 100$+ stock.
DRTS should (and will) show up more once people realize
That’s a great average! Don’t let the short term wavering (if there will be any) get to you, you’ll be telling the story of how you bought DRTS at single digits later this year.
Bear case is any kind of disapproval, but this might be the most de-risked biotech on the market. DRTS has a revolutionary cancer treatment, could treat the most high unmet needs cancers (including Pancreas and GBM), it’s a one session treatment, doesn’t need any special equipment, and it’s the same for all solid tumors. It has 5 (!) trials going on, all with amazing results, the most advanced in Phase 3 and started submitting the data to the FDA. The FDA LOVES them, granted them FDA Breakthrough Device Designation, FDA TAP program, FDA MDSAP certification and so much more (all exclusive and prestigious and fast tracking). And the FDA won’t even be the first approval, the PMDA in Japan is set to approve them very soon. They have an experienced team, a strong cash position, building the commercial facilities and so much more.
Look no further than DRTS. Ask me anything I’d love to tell anyone more about it
Look no further than DRTS. Ask me anything I’d love to tell anyone more about it
In the cancer market there aren’t any competitors, we need everyone to succeed. It’s true morally, but also business wise sadly there’s enough patients for everyone. And even more so with DRTS, because it could be used in addition to any with how safe it is, so every “competitor” actually expands their TAM.
DRTS looks pretty decent . They will probably have to raise cash within a year or year and a half. I haven’t had a chance to really dig in to see what they are doing , or what potential pipeline they have. But right off the bat it seems better than most of the stocks mentioned here lol. Only concern would be the headquarters in Jerusalem , which some people likely wouldn’t be liking that. (I personally have no problem with it. I just stay away from china and Singapore stocks )
Alpha Tau Medical ($DRTS) is perhaps even more promising on paper and have disruptive technology that has been really effective so far in treating tumors. Highly recommend you to DD it!! You could check out DRTS sub in reddit also to learn more about the company. It kind of has that "too good to be true" vibe about it, but maybe sometimes it can be lol
SLS DRTS IBRX trying to stack that cheese like T.I.
Love seeing DRTS in there!
I like this stock and I wanna beat cancer. I got in yesterday (probably not the smartest) and I’ve lost a good amount. But I’m holding and not letting go. This thing is the real deal. Same with DRTS
Thank you 😔. And for you DRTS. Every passing day the trial doesn't end looks better for a new cancer therapy.
Wasn’t DRTS a penny like a week ago?
IBRX. That’s supposedly the next big runner. Shit ton of options expired ITM today. Thinking a crap ton of naked calls. They’ll be able to cover but it already has had solid three days of running! After hours popped again! Possibly running some more next week! Go read up on it and make your decision. It’ll be a wild ride for sure! The question is are you regarded enough? A lot of people call these different tickets scams and garbage. Who the heck know if they’ll continue to run like PLTR or ASTS. Samsies I don’t pick that PLTR horse and look where that mutha is now! Cathy woods was confident on PLTR while it dumped look at that now! Her latest is DRTS! What will become of that who knows. Another strange candidate DRMA, go look at the short interest on that and the borrow rate and low float. Soon enough a run is going to be made on it, maybe…. lol. No one was taking about MLEC a few screeners caught it this week. I saw it on the NYSE LULD halts page and it ran for a hot second. Go look at the 1 minute on that this week! So there are so many and they are all a gamble unless you are in on the run! That’s the current trends say what you will. Microcap and penny stocks with low float so on and so forth with lock ups and low authorized shares with high short interest and CTB. It surely isn’t easy. But they are there!
$98 million currently, as 26 million warrants were excercised. That still leaves about 40 million warrants that can be excercised at a minimum of $1 per warrant. So further dilution is very unlikely. Current burn rate is about 7 million per quarter, although likely to increase a bit due to new, additional, trials starting soon. And yes, I believe this is my next (and hopefully biggest) money maker after RKLB, ASTS, PBC and DRTS. Bought in recently with MDAI as well.
I think 500M is the minimum to mention a stonk right? DRTS is the real IBRX. They’re using local alpha radiation to destroy tumors (including pancreatic) and it’s eliciting a sustained immune response against cancerous tumors in general. Aka, it’s training the body’s immune system to fight future cancers while removing the current tumors. More studies needed but it looks insanely promising.
Very happy in DRTS land!